Graft-v-host disease is associated with autoimmune-like thrombocytopenia.

TitleGraft-v-host disease is associated with autoimmune-like thrombocytopenia.
Publication TypeJournal Article
Year of Publication1989
AuthorsAnasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ
Pagination1054 - 8
Date Published1989
ISBN Number0006-4971
Other Numbersa8g, 7603509
Keywords*Graft vs Host Disease/co [Complications], *Thrombocytopenia/et [Etiology], Adolescent, Adult, Autoimmune Diseases/bl [Blood], Autoimmune Diseases/et [Etiology], Blood Platelets, Child, Child, Preschool, Female, Fibrinogen, Graft vs Host Disease/bl [Blood], Humans, Male, Middle Aged, Thrombocytopenia/bl [Blood]

Persistent thrombocytopenia after allogeneic marrow transplantation is associated with poor patient survival. To identify the mechanisms of the thrombocytopenia, we studied platelet and fibrinogen kinetics and antiplatelet antibodies in 20 patients between 60 and 649 days (median 90) after transplantation. Seventeen patients had isolated thrombocytopenia (less than 100 X 10(9) platelets/L): the marrow cellularity was normal in five patients and slightly reduced in 12, and there was no discrepancy between thrombopoiesis and myeloerythropoiesis. Three patients had pancytopenia following marrow graft rejection (two) and relapse of leukemia (one). Only three patients had evidence of increased platelet production, indicating that in most cases there is a poor marrow response to thrombocytopenia early after marrow grafting. There was no correlation between platelet count and splenic pooling, suggesting that hypersplenism was an unlikely mechanism of the thrombocytopenia. Although there was a direct relationship between platelet count and platelet survival, the reduction in platelet survival was greater than what could be explained by the fixed platelet removal found in thrombocytopenic patients; this suggests increased platelet destruction. Seven patients had intercurrent infections that reduced both platelet and fibrinogen survivals. In addition, platelet antibodies bound to autologous or marrow donor platelets were present in five of the 12 patients studied. Patients with antiplatelet antibodies had lower platelet counts (30 +/- 10 X 10(9)/L v. 49.1 +/- 28.7 X 10(9)/L, P less than 0.05) and platelet survivals (1.32 +/- 0.92 days v. 3.58 +/- 2.02 days, P less than 0.05) than patients without antiplatelet antibodies. Furthermore, platelet-bound autoantibodies were present in five of six patients with grade II-IV acute or chronic graft-versus-host disease (GVHD), but were not present in six patients free of GVHD (P less than 0.01). We conclude that persistent thrombocytopenia after marrow transplantation is most often secondary to increased platelet destruction mediated by multiple mechanisms and that platelet autoantibodies are found in patients with acute or chronic GVHD.

Notify Library Reference ID4422

Related Incidents